Clene’s CNM-Au8 Shows Decreased Mortality Amyotrophic Lateral Sclerosis Patients
Clene Inc (NASDAQ:CLNN) reported significantly improved survival in Amyotrophic lateral sclerosis (ALS) patients initially treated with CNM-Au8 compared to initially randomized…